Join the Conjunctivitis - Allergic group to help and get support from people like you.
Conjunctivitis - Allergic News
Related terms: Allergic Conjunctivitis, Conjunctivitides, allergic
Now Available Over the Counter, Lastacaft Provides Eye Allergy Itch Relief in Minutes that Lasts Through 16 Hours
Itchy allergy eyes affect an estimated 40% of Americans1 Lastacaft is a once-daily eye drop that works within minutes against seasonal and year-round allergens to relieve itchy eyes Previously...
Ocular Therapeutix Announces FDA Approval of sNDA for Dextenza (dexamethasone ophthalmic insert) 0.4 mg for Intracanalicular Use for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis
BEDFORD, Mass.--(BUSINESS WIRE)--Oct. 11, 2021-- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative...
Nicox Receives FDA Approval of Zerviate (cetirizine ophthalmic solution) 0.24%
Sophia Antipolis, France, May 31, 2017 – Nicox S.A. (Euronext Paris: FR0013018124, COX), the international ophthalmic R&D company, today announced that the U.S. Food and Drug Administration (FDA)...
Alcon Receives FDA Approval of Pazeo (olopatadine HCl) Ophthalmic Solution for Allergic Conjunctivitis
Basel, Switzerland, February 2, 2015 – Alcon, the global leader in eye care and a division of Novartis, has received approval from the U.S. Food and Drug Administration (FDA) of Pazeo (olopatadine h...
FDA Approves Tris Pharma's New Drug Application for Karbinal ER
MONMOUTH JUNCTION, N.J., April 3, 2013 /PRNewswire/ – Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that the U.S. Food...
FDA Approves Lastacaft (alcaftadine ophthalmic solution) for Prevention of Itching Associated with Allergic Conjunctivitis
July 28, 2010 – The United States Food and Drug Administration (FDA) has approved Lastacaft (alcaftadine ophthalmic solution) for the prevention of itching associated with allergic conjunctivitis in...
Ista Pharmaceuticals' Bepreve Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies
IRVINE, Calif., September 08, 2009 /PRNewswire-FirstCall/ – ISTA Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved Bepreve (bepotastine besilate...
Ask a question
To post your own question to this support group, sign in or create an account.